AL
SCG

Aspiriant LLC’s Scana SCG Stock Holding History

Aspiriant LLC’s Portfolio SCG Stock Details SCG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-4,754
Closed -$231K – 200
2017
Q3 		$231K Sell
4,754
-6,949
-59% -$426K 0.02% 183
2017
Q2 		$784K Sell
11,703
-947
-7% -$63.6K 0.07% 126
2017
Q1 		$827K Sell
12,650
-1,811
-13% -$125K 0.07% 127
2016
Q4 		$1.06M Buy
14,461
+368
+3% +$26.3K 0.1% 106
2016
Q3 		$1.02M Buy
14,093
+8,497
+152% +$621K 0.1% 105
2016
Q2 		$283K Sell
5,596
-9,838
-64% -$689K 0.03% 158
2016
Q1 		$1.08M Buy
+15,434
New +$998K 0.1% 101

Other funds holding SCG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Aspiriant LLC's SCG Position: Q4 2017 in Review

Aspiriant LLC sold out of Scana (SCG) in Q4 2017, closing a stake of 4,754 shares — an estimated $231K sold.

Aspiriant LLC first reported a position in SCG in Q1 2016 and held it in 7 quarters. The position peaked at $1.08M in Q1 2016. 480 funds tracked by Wall St. Rank hold SCG as of Q4 2017.

  • Aspiriant LLC reported no remaining Scana position as of Q4 2017 after selling out during the quarter.
  • Aspiriant LLC sold 4,754 Scana shares in Q4 2017, an estimated $231K.
  • Aspiriant LLC first reported a position in Scana in Q1 2016 and held it in 7 quarters.
  • Aspiriant LLC's Scana position peaked at $1.08M in Q1 2016.
  • 480 funds tracked by Wall St. Rank held Scana as of Q4 2017.

Based on Aspiriant LLC's 13F filing for Q4 2017, filed 31 Jan 2018.